Craft
  • Home
  •  / Accent Therapeutics
Accent Therapeutics

Accent Therapeutics

Total Funding

$103 M

Accent Therapeutics Summary

Company summary

Overview
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. It focuses on the design of potent drug molecules that selectively inhibit RNA-modifying proteins (RMPs) driving cancer.
Type
Private
Founded
2017
HQ
Lexington, MA, US | view all locations
Website
https://www.accenttx.com/
Cybersecurity rating
Sectors

Key people

  • Ann Boriack-Sjodin

    Ann Boriack-Sjodin, Vice President Molecular Discovery

    • Robert A. Copeland

      Robert A. Copeland, President, Co-Founder, Chief Scientific Officer

      • Kenneth Duncan

        Kenneth Duncan, Vice President Chemistry

        • Nicole Heifner

          Nicole Heifner, Chief Financial Officer

          LocationsView all

          1 location detected

          • Lexington, MA HQ

            United States

            65 Hayden Ave

          Footer menu